Evolent Health Inc reports results for the quarter ended December 31 - Earnings Summary

• Evolent Health Inc EVH.N reported quarterly adjusted earnings of 8 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -2 cents. The mean expectation of fourteen analysts for the quarter was for earnings of 6 cents per share. Wall Street expected results to range from 2 cents to 20 cents per share.

• Revenue fell 24.6% to $468.72 million from a year ago; analysts expected $468.81 million.

• Evolent Health Inc's reported EPS for the quarter was a loss of $3.84​.

• The company reported a quarterly loss of $429.13 million.

• Evolent Health Inc shares had fallen by 30.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 44.9% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Evolent Health Inc is $8.50, about 69.9% above its last closing price of $2.56

This summary was machine generated from LSEG data February 24 at 11:15 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)